28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Related
The fact that a merger might be anticompetitive is not a reason to prohibit a transaction if all of ...
Read More >
Last year, the Washington Supreme Court considered the following certified question: “Does the Wash...
Read More >
This is the first installment of a two-part series highlighting M&A transaction issues for buyers an...
Read More >
The compliance component of your M&A regime should begin with a preliminary pre-acquisition assessme...
Read More >
On March 26, the Secretary of Energy authorized Department of Energy (DOE) contracting officers to e...
Read More >
When is it going to return to “normal”? We all have been asking that question. Well, for the const...
Read More >